Yarrow Bioscience, Inc. (YARW)
37.00
-1.00
(-2.63%)
USD |
NASDAQ |
Aug 28, 16:00
37.40
+0.40
(+1.08%)
After-Hours: 20:00
Yarrow Bioscience Price to Book Value : 1.121 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.121 |
| August 27, 2026 | 1.151 |
| August 26, 2026 | 1.201 |
| August 25, 2026 | 1.189 |
| August 24, 2026 | 1.196 |
| August 21, 2026 | 1.103 |
| August 20, 2026 | 1.157 |
| August 19, 2026 | 1.230 |
| August 18, 2026 | 1.258 |
| August 17, 2026 | 1.254 |
| August 14, 2026 | 1.287 |
| August 13, 2026 | 1.294 |
| August 12, 2026 | 1.296 |
| August 11, 2026 | 1.301 |
| August 10, 2026 | 1.271 |
| August 07, 2026 | 1.255 |
| August 06, 2026 | 1.261 |
| August 05, 2026 | 1.142 |
| August 04, 2026 | 1.150 |
| August 03, 2026 | 1.018 |
| July 31, 2026 | 1.061 |
| July 30, 2026 | 0.9993 |
| July 29, 2026 | 0.9224 |
| July 28, 2026 | 0.8497 |
| July 27, 2026 | 0.8651 |
| Date | Value |
|---|---|
| July 24, 2026 | 0.7709 |
| July 23, 2026 | 1.399 |
| July 22, 2026 | 1.360 |
| July 21, 2026 | 1.352 |
| July 20, 2026 | 1.224 |
| July 17, 2026 | 1.153 |
| July 16, 2026 | 1.162 |
| July 15, 2026 | 1.147 |
| July 14, 2026 | 1.077 |
| July 13, 2026 | 0.9965 |
| July 10, 2026 | 0.9657 |
| July 09, 2026 | 1.018 |
| July 08, 2026 | 0.9848 |
| July 07, 2026 | 1.014 |
| July 06, 2026 | 1.011 |
| July 02, 2026 | 1.030 |
| July 01, 2026 | 1.031 |
| June 30, 2026 | 0.9855 |
| June 29, 2026 | 0.8766 |
| June 26, 2026 | 0.8777 |
| June 25, 2026 | 0.8823 |
| June 24, 2026 | 0.8808 |
| June 23, 2026 | 0.88 |
| June 22, 2026 | 0.88 |
| June 18, 2026 | 0.8602 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Oramed Pharmaceuticals, Inc. | 0.6546 |
| NRX Pharmaceuticals, Inc. | -- |
| ANI Pharmaceuticals, Inc. | 2.802 |
| Corcept Therapeutics, Inc. | 17.41 |
| Veru, Inc. | 1.577 |
Price to Book Value Related Metrics
| PS Ratio | 62.10 |
| Price | 37.00 |
| Earnings Yield | -63.40% |
| Market Cap | 24.73M |